318 related articles for article (PubMed ID: 10510358)
21. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
22. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
23. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.
Delgado M; Gonzalez-Rey E; Ganea D
FASEB J; 2004 Sep; 18(12):1453-5. PubMed ID: 15231725
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK.
Mukohyama H; Ransjö M; Taniguchi H; Ohyama T; Lerner UH
Biochem Biophys Res Commun; 2000 Apr; 271(1):158-63. PubMed ID: 10777696
[TBL] [Abstract][Full Text] [Related]
25. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.
Ding L; Linsley PS; Huang LY; Germain RN; Shevach EM
J Immunol; 1993 Aug; 151(3):1224-34. PubMed ID: 7687627
[TBL] [Abstract][Full Text] [Related]
26. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide.
Delgado M; Leceta J; Abad C; Martinez C; Ganea D; Gomariz RP
J Neuroimmunol; 1999 Sep; 99(1):61-71. PubMed ID: 10496178
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.
Delgado M; Ganea D
J Neuroimmunol; 2000 Oct; 110(1-2):97-105. PubMed ID: 11024538
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive Intestinal Peptide and pituary adenylate cyclase-activating polypeptide inhibit tissue factor expression in monocyte in vitro and in vivo.
Lv B; Tang Y; Chen F; Xiao X
Shock; 2009 Feb; 31(2):185-91. PubMed ID: 18650785
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
[TBL] [Abstract][Full Text] [Related]
30. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
Soares MB; Titus RG; Shoemaker CB; David JR; Bozza M
J Immunol; 1998 Feb; 160(4):1811-6. PubMed ID: 9469441
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity.
Ganea D; Delgado M
Crit Rev Oral Biol Med; 2002; 13(3):229-37. PubMed ID: 12090463
[TBL] [Abstract][Full Text] [Related]
32. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression.
Cong Y; Weaver CT; Elson CO
J Immunol; 1997 Dec; 159(11):5301-8. PubMed ID: 9548469
[TBL] [Abstract][Full Text] [Related]
33. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development.
DiCicco-Bloom E; Deutsch PJ; Maltzman J; Zhang J; Pintar JE; Zheng J; Friedman WF; Zhou X; Zaremba T
Dev Biol; 2000 Mar; 219(2):197-213. PubMed ID: 10694416
[TBL] [Abstract][Full Text] [Related]
34. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
35. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
Nikcevich KM; Gordon KB; Tan L; Hurst SD; Kroepfl JF; Gardinier M; Barrett TA; Miller SD
J Immunol; 1997 Jan; 158(2):614-21. PubMed ID: 8992975
[TBL] [Abstract][Full Text] [Related]
38. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
39. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages.
Flores Villanueva PO; Reiser H; Stadecker MJ
J Immunol; 1994 Dec; 153(11):5190-9. PubMed ID: 7525726
[TBL] [Abstract][Full Text] [Related]
40. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
Leceta J; Gomariz RP; Martinez C; Abad C; Ganea D; Delgado M
Ann N Y Acad Sci; 2000; 921():92-102. PubMed ID: 11193883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
